Our previous study also provided evidence that A20 elevates TGF-β signaling, suggesting that A20 could promote a TGF-β-meditated EMT pathway and tumor aggressiveness in HER2-positive breast cancer. The gene discussed is TNFAIP3; the disease is neoplasm.